anti-VEGF agentsretinopathy of prematurityzone I and zone II posterior diseasezone I diseaseROPlaser treatment
…nd rates of reactivation vary depending on the type and dose of anti-VEGF agents, with occurrences sometimes delayed for years after an initial …